Today: 26 April 2026
US economic calendar today: Stocks slide on tariff reset as factory orders fall, Fed in focus
23 February 2026
2 mins read

US economic calendar today: Stocks slide on tariff reset as factory orders fall, Fed in focus

New York, February 23, 2026, 14:35 ET — Regular session

  • The S&P 500 slipped roughly 1.1% in afternoon trading, with tariff jitters resurfacing. Gold and volatility both pushed higher.
  • Factory orders slipped 0.7% in December, while the Chicago Fed’s activity gauge moved back into positive territory in January.
  • This week, traders are watching for new inflation and confidence numbers, and bracing for a wave of major earnings—Nvidia sits at the top of that list.

Stocks in the U.S. slipped Monday, the S&P 500 losing roughly 1.1%. The Dow shed about 1.6% by the afternoon. Over in ETFs, the SPDR S&P 500 ETF Trust dropped 1.1% to $681.87. Gold, meanwhile, pushed up 2.2%, and a short-term volatility product jumped almost 3%.

Investors scrambled to adjust after the Supreme Court wiped out President Donald Trump’s emergency tariffs on Friday, triggering a sharp selloff. Trump responded fast, rolling out a sweeping new tariff plan: 10% on all imports at first, with a bump to 15%. The market’s left in limbo—nobody knows yet when the new rules kick in, who gets exempted, or how much extra inflation they’ll spark.

The stakes are high right now, with traders caught between a packed data schedule and every Fed comment shifting the market’s view on rates. “It looks like a resumption of the AI disruption selloff,” said Ross Mayfield, investment strategy analyst at Baird. Tariff news sent risk appetite on a wild ride, making things even choppier. Reuters

Factory orders in the U.S. slid 0.7% in December, landing at $617.5 billion, according to the Commerce Department’s Census Bureau. Shipments, meanwhile, ticked up 0.5%. Inventories barely budged, rising just 0.1%.

January’s Chicago Fed National Activity Index came in at 0.18, up from December’s -0.21, data from the St. Louis Fed’s FRED database show. A reading above zero points to growth above the long-term trend.

The Dallas Fed’s Texas Manufacturing Outlook Survey came in steady, not sizzling. The general business activity index ticked up to 0.2 from -1.2. Production didn’t budge, holding at 12.5, according to the bank.

Treasury yields slipped, with traders eyeing tariff adjustments and the chance that refund lawsuits might push up government borrowing. The 10-year benchmark hovered near 4.07%. ING analysts flagged that “the risk of escalation is now higher” as trade-policy frictions made a comeback. Reuters

Stock moves were mixed. Domino’s Pizza jumped 3.9% to $399.70 after topping U.S. same-store sales forecasts, thanks to value offers. CEO Russell Weiner said the company is targeting more U.S. pizza market share.

PayPal surged 5.6% to $44.00 after Bloomberg flagged takeover interest, Reuters said. Eli Lilly advanced 4.2% to $1,051.50, boosted by weaker-than-expected results from Novo Nordisk’s obesity-drug study. That sent Novo’s U.S. shares tumbling 16.4%.

Fed Governor Christopher Waller signaled he’s open to keeping rates unchanged in March, provided February’s jobs data builds on January’s gains. He flagged the March 6 payrolls release as the crucial checkpoint before the March 17–18 policy decision.

The tape’s chasing a moving target here. Tariff carve-outs, shifting start dates, or another round of retaliation—any of it could force investors to rapidly rethink both earnings projections and inflation calls. And if refunding and deficit worries start looking like actual funding problems, it’s tough to bet on bond market stability.

Coming Tuesday, investors will get a look at Case-Shiller and FHFA home-price numbers at 9 a.m. ET. Consumer confidence and the Richmond Fed factory index both cross the wires an hour later, at 10 a.m. ET. Eyes also turn to Friday’s PPI, which drops at 8:30 a.m. ET.

Stock Market Today

  • AMD Shares Surge 13.85% on Strong AI Demand and Analyst Upgrade
    April 25, 2026, 11:10 PM EDT. Shares of Advanced Micro Devices (AMD) jumped 13.85% on Friday after D.A. Davidson analyst Gil Luria upgraded the stock to buy and raised the price target to $375. Luria cited Intel's strong earnings report highlighting robust data center chip sales as a sign of rising demand for high-speed central processing units (CPUs) powering artificial intelligence (AI) agents. The shift towards agentic AI workloads is boosting server CPU demand, benefiting AMD. Luria also noted that with demand outstripping supply, AMD could increase prices on high-performance CPUs, improving margins and profits. Investors await AMD's Q1 financial results and management's conference call on May 5 for more insights on its AI-driven growth prospects.

Latest article

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

26 April 2026
Lockheed Martin was named among firms awarded up to $3.2 billion for President Trump’s Golden Dome space-based missile interceptor plan, Space Systems Command said. The company reported weaker first-quarter results, with $18 billion in sales and negative free cash flow. Space Force aims to show initial interceptor capability in 2028. Golden Dome’s total cost is projected at $185 billion.
ASML Stock’s AI Boom Has a Catch: TSMC Won’t Rush the $410 Million Machine

ASML Stock’s AI Boom Has a Catch: TSMC Won’t Rush the $410 Million Machine

26 April 2026
ASML shares rose 2.3% in Amsterdam late Friday as the company reported Q1 net sales of €8.8 billion and raised its 2026 sales outlook to up to €40 billion. TSMC, ASML’s top customer, said it would delay adopting ASML’s new High-NA EUV machines, priced at over €350 million each, preferring to extend use of existing tools. ASML aims to deliver at least 60 standard EUV machines in 2026.
Rackspace (RXT) stock back in play as Palantir AI deal meets earnings week
Previous Story

Rackspace (RXT) stock back in play as Palantir AI deal meets earnings week

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop